Summary
My research focuses on health economic analyses of infectious diseases in low and middle-income countries. I specialize and have extensive experience in performing costings of healthcare interventions, cost of illness analysis and cost-effectiveness analysis. I work on projects on a wide range of infectious diseases (including neglected tropical diseases, dengue, HCV, HPV, hospital-acquired infections, and tetanus). I have conducted fieldwork in Ghana and Kenya and was based at a research unit in Vietnam for over three years. The goal of my research career is to use health economics to help optimise healthcare policy in low and middle-income countries.
Selected Publications
Journal Articles
Mathew CG, Bettis AA, Chu BK, et al., 2020, The health and economic burdens of lymphatic filariasis prior to mass drug administration programs, Clinical Infectious Diseases, Vol:70, ISSN:1058-4838, Pages:2561-2567
Deribe K, Negussu N, Newport MJ, et al., 2020, The health and economic burden of podoconiosis in Ethiopia, Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol:114, ISSN:0035-9203, Pages:284-292
Turner HC, Lauer JA, Tran BX, et al., 2019, Adjusting for inflation and currency changes within health economic studies, Value in Health, Vol:22, ISSN:1098-3015, Pages:1026-1032
Turner HC, Nguyen VH, Yacoub S, et al., 2019, Achieving affordable critical care in low-income and middle-income countries, Bmj Global Health, Vol:4, ISSN:2059-7908, Pages:1-4
Turner HC, Toor J, Bettis AA, et al., 2019, Valuing the unpaid contribution of community health volunteers to mass drug administration programs, Clinical Infectious Diseases, Vol:68, ISSN:1058-4838, Pages:1588-1595
Hung TM, Clapham HE, Bettis AA, et al., 2018, The estimates of the health and economic burden of dengue in Vietnam, Parasitology Today, Vol:34, ISSN:0169-4758, Pages:904-918
Turner HC, Thwaites GE, Clapham HE, 2018, Vaccine-preventable diseases in lower-middle-income countries, Lancet Infectious Diseases, Vol:18, ISSN:1473-3099, Pages:937-939
Turner HC, Toor J, Hollingsworth TD, et al., 2018, Economic evaluations of mass drug administration: the importance of economies of scale and scope, Clinical Infectious Diseases, Vol:66, ISSN:1058-4838, Pages:1298-1303
Turner HC, Bettis AA, Chu BK, et al., 2017, Investment success in public health: an analysis of the cost-effectiveness and cost-benefit of the global programme to eliminate lymphatic filariasis, Clinical Infectious Diseases, Vol:64, ISSN:1058-4838, Pages:728-735
Turner HC, Truscott JE, Fleming FM, et al., 2016, Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses., Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:838-846
Turner HC, Truscott JE, Hollingsworth TD, et al., 2015, Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs., Parasites & Vectors, Vol:8, ISSN:1756-3305
Turner HC, Walker M, French MD, et al., 2014, Neglected tools for neglected diseases: mathematical models in economic evaluations, Trends in Parasitology, Vol:30, ISSN:1471-4922, Pages:562-570
Turner HC, Walker M, Churcher TS, et al., 2014, Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa, Clinical Infectious Diseases, Vol:59, ISSN:1058-4838, Pages:923-932